FDAnews Announces -- EU-MDR: Are You Ready? Part I: The Real Role of the Person Responsible for Regulatory Readiness & Compliance Webinar, Feb. 20, 2020
What did the European Commission have in mind when they asked medical device companies to appoint a PRRC? Join us Feb. 20 to learn more.
FALLS CHURCH, Va., Feb. 6, 2020 /PRNewswire-PRWeb/ -- EU-MDR: Are You Ready?
Part I: The Real Role of the Person Responsible for Regulatory Readiness & Compliance
An Exclusive Three-Part FDAnews Webinar Series
Thursday, Feb. 20, 2020 • 1:30 p.m.-3:00 p.m. EST
https://www.fdanews.com/part1eumdr
The European Union is requiring medical device companies to appoint a Person Responsible for Regulatory Compliance (PRRC). Get ready for EU-MDR's deadline in May.
Does one's organization have a change management processes in place to support the PRRC and ensure their success?
Join us for a webinar on Feb. 20 to get a better sense of what the PRRC does to supervise and control the change management process as well as the release of product onto the market.
- Find out why a PRRC is required in the first place and what is the PRRC duties and responsibilities
- Determine whether the PRRC is over or under qualified or unable to fulfil their duties due to tasks overload
- Get a sense of the relationship between the PRRC and the strategy set for regulatory compliance
- Discover how the processes of a medical device manufacturer and other economic operators should be planned in order to fulfil the requirements for a PRRC
- Critically evaluate whether your corporate structure is ready to ensure supervision and control of products to achieve EU regulatory compliance
- Familiarize yourself with the importance of organizational design to ensure the various roles participating in compliance are understood and coordinated
Prepare for the new PPRC requirement today!
This webinar is part one of a three-part online series on EU-MDR readiness. Save 25% by registering for the complete three-part series:
Part II: Tips for Assessing Your Readiness Prior to Notified Body Review
Thursday, March 26, 2020, 1:30 p.m.-3:00 p.m. EDT
Part III: After May 2020, Ensuring Your Post-Market Surveillance Readiness via a Risk Management Framework
Thursday, April 23, 2020, 1:30 p.m.-3:00 p.m. EDT
Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.
Webinar Details:
EU-MDR: Are You Ready?
Part I: The Real Role of the Person Responsible for Regulatory Readiness & Compliance
An Exclusive Three-Part FDAnews Webinar Series
Thursday, Feb. 20, 2020 • 1:30 p.m.-3:00 p.m. EST
https://www.fdanews.com/part1eumdr
Tuition:
$287 per site
Easy Ways to Register:
Online: https://www.fdanews.com/part1eumdr
By phone: 888.838.5578 or 703.538.7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
SOURCE FDAnews
Share this article